Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Assets (2023 - 2025)

Historic Assets for Metagenomi (MGX) over the last 3 years, with Q3 2025 value amounting to $247.9 million.

  • Metagenomi's Assets fell 3081.11% to $247.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $247.9 million, marking a year-over-year decrease of 3081.11%. This contributed to the annual value of $324.6 million for FY2024, which is 1103.03% down from last year.
  • According to the latest figures from Q3 2025, Metagenomi's Assets is $247.9 million, which was down 3081.11% from $272.3 million recorded in Q2 2025.
  • Over the past 5 years, Metagenomi's Assets peaked at $415.4 million during Q1 2024, and registered a low of $247.9 million during Q3 2025.
  • Its 3-year average for Assets is $333.4 million, with a median of $341.5 million in 2024.
  • Its Assets has fluctuated over the past 5 years, first crashed by 1103.03% in 2024, then crashed by 3081.11% in 2025.
  • Metagenomi's Assets (Quarter) stood at $364.8 million in 2023, then dropped by 11.03% to $324.6 million in 2024, then dropped by 23.62% to $247.9 million in 2025.
  • Its Assets stands at $247.9 million for Q3 2025, versus $272.3 million for Q2 2025 and $297.9 million for Q1 2025.